Cyclosporin A increases recovery after spinal cord injury but does not improve myelination by oligodendrocyte progenitor cell transplantation

<p>Abstract</p> <p>Background</p> <p>Transplantation of oligodendrocyte precursor cells (OPCs) is an attractive therapy for demyelinating diseases. Cyclosporin A (CsA) is one of the foremost immunosuppressive agents and has widespread use in tissue and cell transplantat...

Full description

Bibliographic Details
Main Authors: Wang Feng-Chao, Zhou Jian-Sheng, Wang Yan-Xia, Lü He-Zuo, Hu Jian-Guo
Format: Article
Language:English
Published: BMC 2010-10-01
Series:BMC Neuroscience
Online Access:http://www.biomedcentral.com/1471-2202/11/127
id doaj-1ae45f3b192a45dba8552c4d5704034c
record_format Article
spelling doaj-1ae45f3b192a45dba8552c4d5704034c2020-11-25T00:28:48ZengBMCBMC Neuroscience1471-22022010-10-0111112710.1186/1471-2202-11-127Cyclosporin A increases recovery after spinal cord injury but does not improve myelination by oligodendrocyte progenitor cell transplantationWang Feng-ChaoZhou Jian-ShengWang Yan-XiaLü He-ZuoHu Jian-Guo<p>Abstract</p> <p>Background</p> <p>Transplantation of oligodendrocyte precursor cells (OPCs) is an attractive therapy for demyelinating diseases. Cyclosporin A (CsA) is one of the foremost immunosuppressive agents and has widespread use in tissue and cell transplantation. However, whether CsA affects survival and differentiation of engrafted OPCs <it>in vivo </it>is unknown. In this study, the effect of CsA on morphological, functional and immunological aspects, as well as survival and differentiation of engrafted OPCs in injured spinal cord was explored.</p> <p>Results</p> <p>We transplanted green fluorescent protein (GFP) expressed OPCs (GFP-OPCs) into injured spinal cords of rats treated with or without CsA (10 mg/kg). Two weeks after cell transplantation, more GFP-positive cells were found in CsA-treated rats than that in vehicle-treated ones. However, the engrafted cells mostly differentiated into astrocytes, but not oligodendrocytes in both groups. In the CsA-treated group, a significant decrease in spinal cord lesion volume along with increase in spared myelin and neurons were found compared to the control group. Such histological improvement correlated well with an increase in behavioral recovery. Further study suggested that CsA treatment could inhibit infiltration of T cells and activation of resident microglia and/or macrophages derived from infiltrating monocytes in injured spinal cords, which contributes to the survival of engrafted OPCs and repair of spinal cord injury (SCI).</p> <p>Conclusions</p> <p>These results collectively indicate that CsA can promote the survival of engrafted OPCs in injured spinal cords, but has no effect on their differentiation. The engrafted cells mostly differentiated into astrocytes, but not oligodendrocytes. The beneficial effect of CsA on SCI and the survival of engrafted cells may be attributed to its neuroprotective effect.</p> http://www.biomedcentral.com/1471-2202/11/127
collection DOAJ
language English
format Article
sources DOAJ
author Wang Feng-Chao
Zhou Jian-Sheng
Wang Yan-Xia
Lü He-Zuo
Hu Jian-Guo
spellingShingle Wang Feng-Chao
Zhou Jian-Sheng
Wang Yan-Xia
Lü He-Zuo
Hu Jian-Guo
Cyclosporin A increases recovery after spinal cord injury but does not improve myelination by oligodendrocyte progenitor cell transplantation
BMC Neuroscience
author_facet Wang Feng-Chao
Zhou Jian-Sheng
Wang Yan-Xia
Lü He-Zuo
Hu Jian-Guo
author_sort Wang Feng-Chao
title Cyclosporin A increases recovery after spinal cord injury but does not improve myelination by oligodendrocyte progenitor cell transplantation
title_short Cyclosporin A increases recovery after spinal cord injury but does not improve myelination by oligodendrocyte progenitor cell transplantation
title_full Cyclosporin A increases recovery after spinal cord injury but does not improve myelination by oligodendrocyte progenitor cell transplantation
title_fullStr Cyclosporin A increases recovery after spinal cord injury but does not improve myelination by oligodendrocyte progenitor cell transplantation
title_full_unstemmed Cyclosporin A increases recovery after spinal cord injury but does not improve myelination by oligodendrocyte progenitor cell transplantation
title_sort cyclosporin a increases recovery after spinal cord injury but does not improve myelination by oligodendrocyte progenitor cell transplantation
publisher BMC
series BMC Neuroscience
issn 1471-2202
publishDate 2010-10-01
description <p>Abstract</p> <p>Background</p> <p>Transplantation of oligodendrocyte precursor cells (OPCs) is an attractive therapy for demyelinating diseases. Cyclosporin A (CsA) is one of the foremost immunosuppressive agents and has widespread use in tissue and cell transplantation. However, whether CsA affects survival and differentiation of engrafted OPCs <it>in vivo </it>is unknown. In this study, the effect of CsA on morphological, functional and immunological aspects, as well as survival and differentiation of engrafted OPCs in injured spinal cord was explored.</p> <p>Results</p> <p>We transplanted green fluorescent protein (GFP) expressed OPCs (GFP-OPCs) into injured spinal cords of rats treated with or without CsA (10 mg/kg). Two weeks after cell transplantation, more GFP-positive cells were found in CsA-treated rats than that in vehicle-treated ones. However, the engrafted cells mostly differentiated into astrocytes, but not oligodendrocytes in both groups. In the CsA-treated group, a significant decrease in spinal cord lesion volume along with increase in spared myelin and neurons were found compared to the control group. Such histological improvement correlated well with an increase in behavioral recovery. Further study suggested that CsA treatment could inhibit infiltration of T cells and activation of resident microglia and/or macrophages derived from infiltrating monocytes in injured spinal cords, which contributes to the survival of engrafted OPCs and repair of spinal cord injury (SCI).</p> <p>Conclusions</p> <p>These results collectively indicate that CsA can promote the survival of engrafted OPCs in injured spinal cords, but has no effect on their differentiation. The engrafted cells mostly differentiated into astrocytes, but not oligodendrocytes. The beneficial effect of CsA on SCI and the survival of engrafted cells may be attributed to its neuroprotective effect.</p>
url http://www.biomedcentral.com/1471-2202/11/127
work_keys_str_mv AT wangfengchao cyclosporinaincreasesrecoveryafterspinalcordinjurybutdoesnotimprovemyelinationbyoligodendrocyteprogenitorcelltransplantation
AT zhoujiansheng cyclosporinaincreasesrecoveryafterspinalcordinjurybutdoesnotimprovemyelinationbyoligodendrocyteprogenitorcelltransplantation
AT wangyanxia cyclosporinaincreasesrecoveryafterspinalcordinjurybutdoesnotimprovemyelinationbyoligodendrocyteprogenitorcelltransplantation
AT luhezuo cyclosporinaincreasesrecoveryafterspinalcordinjurybutdoesnotimprovemyelinationbyoligodendrocyteprogenitorcelltransplantation
AT hujianguo cyclosporinaincreasesrecoveryafterspinalcordinjurybutdoesnotimprovemyelinationbyoligodendrocyteprogenitorcelltransplantation
_version_ 1725334395302182912